跳至主要内容
临床试验/NL-OMON39520
NL-OMON39520已完成2 期

Evaluation of the effect of psycho-oncological intervention on well-being of patients with advanced prostate cancer on LHRH analogs and their partners. A randomized controlled pilot study. - EXPEDIENT

Ipsen Pharmaceuticals0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patient and partner must give written (personally signed and dated) informed consent before completing any study-related procedure.
  • - Histologically confirmed diagnosis of prostate cancer on biopsy.
  • - Locally advanced or metastasised prostate cancer in need of hormonal treatment.
  • - On LHRH analogue treatment for a minimum of 5 months (at inclusion).
  • - Patients and their partner are able to fill out questionnaires, attend group sessions and give consent
  • - Having a female partner

排除标准

  • -Serious psychiatric difficulties
  • -Life expectancy < 12 months

研究者

发起方
Ipsen Pharmaceuticals

相似试验